Weld Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Weld Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,672	Closed	-$230K	–	816
2019 Q4	$230K	Sell	11,672 -48,213	-81%	-$771K	0.04%	511
2019 Q3	$776K	Buy	59,885 +47,095	+368%	+$569K	0.14%	238
2019 Q2	$159K	Sell	12,790 -30,628	-71%	-$407K	0.03%	670
2019 Q1	$631K	Sell	43,418 -4,578	-10%	-$58.5K	0.11%	327
2018 Q4	$530K	Buy	+47,996	New	+$668K	0.12%	325

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Weld Capital Management's MNTA Position: Q1 2020 in Review

Weld Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 11,672 shares — an estimated $230K sold.

Weld Capital Management first reported a position in MNTA in Q4 2018 and held it in 5 quarters. The position peaked at $776K in Q3 2019. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

Weld Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Weld Capital Management sold 11,672 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $230K.
Weld Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2018 and held it in 5 quarters.
Weld Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $776K in Q3 2019.
199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Weld Capital Management's 13F filing for Q1 2020, filed 15 May 2020.